VPS37A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.27639998570572E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.635900E-04 |
Normal-vs-Stage2 |
1.802720E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.999820E-03 |
Stage1-vs-Stage2 |
6.156200E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.576600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.202600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.00529999880195E-08 |
Normal-vs-AfricanAmerican |
4.355400E-01 |
Normal-vs-Asian |
1.284450E-01 |
Caucasian-vs-AfricanAmerican |
7.236200E-01 |
Caucasian-vs-Asian |
6.664200E-01 |
AfricanAmerican-vs-Asian |
7.396200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.54760000000388E-05 |
Normal-vs-Female |
3.86289999998457E-06 |
Male-vs-Female |
4.942200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.741300E-03 |
Normal-vs-Extreme_Weight |
2.19989999999948E-05 |
Normal-vs-Obese |
5.024600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.272800E-01 |
Normal_Weight-vs-Obese |
2.095800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.524820E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.28600000040657E-08 |
Normal-vs-Age(41-60Yrs) |
1.939990E-03 |
Normal-vs-Age(61-80Yrs) |
2.06160000004729E-06 |
Normal-vs-Age(81-100Yrs) |
1.953840E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.428990E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.075100E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.956300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.490600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.098800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.910600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.705400E-01 |
Normal-vs-Grade 3 |
8.778800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.973600E-01 |
Grade 2-vs-Grade 4 |
9.705400E-01 |
Grade 3-vs-Grade 4 |
8.778800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.85389999998831E-06 |
Normal-vs-N1 |
4.804100E-03 |
N0-vs-N1 |
2.255200E-01 |
|
|